The therapeutic progress for adults with acute lymphoblastic leukemia (ALL) has been slow, with a 5-year survival of 30% to 45% in developed countries. Scarce information is available regarding the treatment and survival rates from nonindustrialized populations. In the present study, the ...
Log In Sign Up Subjects Health & Medicine What is the survival rate for acute myeloid leukemia?Question:What is the survival rate for acute myeloid leukemia?Risk factors for acute myeloid leukemia:Acute myeloid leukemia is usually seen in older adults and the risk increases in individuals ...
Acute lymphocytic leukemia(ALL, also known as acute lymphoblastic leukemia) is the most common type of leukemia in children, but it can also affect adults. In this type of leukemia, immature lymphoid cells grow rapidly in the blood. It affects almost 6,000 people per year in the U.S. Acu...
For adults with acute myeloid leukemia (AML), those with central nervous system (CNS) involvement have worse overall survival, according to a review published in the February issue ofLeukemia Research. Hannah Goulart, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and...
Treatment of acute lymphoblastic leukemia (ALL) has improved enormously in the last 40 years particularly in children in whom a long-term survival of 80% is now achieved.1, 2, 3, 4 Adults have fared much worse; the survival in the best series may not even reach 35% to 40% for those...
ALL is also known as acute lymphocyticleukemiaor acute lymphoid leukemia. ”Acute” means it gets worse quickly. It’s a rare type of leukemia, or blood cancer, in adults but the most common type in children. Acute lymphoblastic leukemia invades your blood and can spread to other organs, su...
Overall survival by day 28 was 94.1%. Cumulative incidence of clinical improvement of ≥2 points in the ordinal scale was 82.4% (95% confidence interval, 71–93). Clinical improvement was not affected by low-flow versus high-flow oxygen support but was less frequent in patients with PaO2/...
We assessed stage-specific trends in primary therapy and relative survival among adult follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N = 12,372; median age, 62 years; and 21% stage I disease). Patients were stratified by disease stage and subsequently ...
survival. The optimal treatment for older patients with AML is unclear. While intensive induction chemotherapy has been used for the last few decades, it has been associated with high treatment-related morbidity and mortality. In the last decade, many advances in the treatment of AML have been ...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell transplantation (alloHSCT), this effect has been ...